These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10970891)

  • 1. Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activator.
    Stewart RJ; Fredenburgh JC; Rischke JA; Bajzar L; Weitz JI
    J Biol Chem; 2000 Nov; 275(47):36612-20. PubMed ID: 10970891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.
    Stewart RJ; Fredenburgh JC; Weitz JI
    J Biol Chem; 1998 Jul; 273(29):18292-9. PubMed ID: 9660794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor.
    Wang W; Boffa MB; Bajzar L; Walker JB; Nesheim ME
    J Biol Chem; 1998 Oct; 273(42):27176-81. PubMed ID: 9765237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of activated thrombin-activatable fibrinolysis inhibitor (TAFIa)-catalyzed cleavage of C-terminal lysine residues of fibrin degradation products and removal of plasminogen-binding sites.
    Foley JH; Cook PF; Nesheim ME
    J Biol Chem; 2011 Jun; 286(22):19280-6. PubMed ID: 21467042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin-activable fibrinolysis inhibitor zymogen does not play a significant role in the attenuation of fibrinolysis.
    Foley JH; Kim P; Nesheim ME
    J Biol Chem; 2008 Apr; 283(14):8863-7. PubMed ID: 18252711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of fibrin cofactor activity in plasminogen activation.
    Nesheim M; Walker J; Wang W; Boffa M; Horrevoets A; Bajzar L
    Ann N Y Acad Sci; 2001; 936():247-60. PubMed ID: 11460482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates fibrin-dependent plasmin generation on thrombin-activated platelets.
    Ni R; Neves MAD; Wu C; Cerroni SE; Flick MJ; Ni H; Weitz JI; Gross PL; Kim PY
    J Thromb Haemost; 2020 Sep; 18(9):2364-2376. PubMed ID: 32506822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambivalent roles of carboxypeptidase B in the lytic susceptibility of fibrin.
    Kovács A; Szabó L; Longstaff C; Tenekedjiev K; Machovich R; Kolev K
    Thromb Res; 2014 Jan; 133(1):80-7. PubMed ID: 24094605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A kinetic analysis of the tissue plasminogen activator and DSPAalpha1 cofactor activities of untreated and TAFIa-treated soluble fibrin degradation products of varying size.
    Walker JB; Nesheim ME
    J Biol Chem; 2001 Feb; 276(5):3138-48. PubMed ID: 11069903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the mechanism responsible for the increased fibrin specificity of TNK-tissue plasminogen activator relative to tissue plasminogen activator.
    Stewart RJ; Fredenburgh JC; Leslie BA; Keyt BA; Rischke JA; Weitz JI
    J Biol Chem; 2000 Apr; 275(14):10112-20. PubMed ID: 10744692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activator.
    Liu JN; Gurewich V
    Blood; 1993 Feb; 81(4):980-7. PubMed ID: 8428004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
    Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
    Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of fibrin fragments to one-chain and two-chain tissue-type plasminogen activator.
    Hasan AA; Chang WS; Budzynski AZ
    Blood; 1992 May; 79(9):2313-21. PubMed ID: 1571544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of tissue-type plasminogen activator binding sites on fibrin using distinct fragments of fibrinogen.
    Grailhe P; Nieuwenhuizen W; Anglés-Cano E
    Eur J Biochem; 1994 Feb; 219(3):961-7. PubMed ID: 8112348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation.
    Suenson E; Bjerrum P; Holm A; Lind B; Meldal M; Selmer J; Petersen LC
    J Biol Chem; 1990 Dec; 265(36):22228-37. PubMed ID: 2148318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
    Liu JN; Gurewich V
    J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator.
    Silva MM; Thelwell C; Williams SC; Longstaff C
    J Thromb Haemost; 2012 Nov; 10(11):2354-60. PubMed ID: 22974122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intrinsic threshold of the fibrinolytic system is modulated by basic carboxypeptidases, but the magnitude of the antifibrinolytic effect of activated thrombin-activable fibrinolysis inhibitor is masked by its instability.
    Walker JB; Bajzar L
    J Biol Chem; 2004 Jul; 279(27):27896-904. PubMed ID: 15128744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrin structures during tissue-type plasminogen activator-mediated fibrinolysis studied by laser light scattering: relation to fibrin enhancement of plasminogen activation.
    Bauer R; Hansen SL; Jones G; Suenson E; Thorsen S; Ogendal L
    Eur Biophys J; 1994; 23(4):239-52. PubMed ID: 7805626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.